IL-18 Blockage Reduces Neuroinflammation and Promotes Functional Recovery in a Mouse Model of Spinal Cord Injury
Biomolecules · 2024
DOI: 10.3390/biom15010016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Easmin Begum und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Developmental Biology, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Shimane, Japan. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Interleukin-18, Recovery of Function, Neuroinflammatory Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Senri Life Science Foundation.
Abstract (Originalsprache)
The prognosis of spinal cord injury (SCI) is closely linked to secondary injury processes, predominantly driven by neuroinflammation. Interleukin-18 (IL-18) plays a pivotal role in this inflammatory response. In previous work, we developed an anti-IL-18 antibody capable of neutralizing the active form of IL-18. This study evaluated the functional effects of this antibody in a mouse model of SCI. IL-18 expression was significantly upregulated in the spinal cord following injury. In a mouse model of SCI (C57BL/6J strain), mice were administered 150 μg of the anti-IL-18 antibody intraperitoneally. IL-18 inhibition via antibody treatment facilitated motor functional recovery post-injury. This intervention reduced neuronal death, reactive gliosis, microglia/macrophage activation, and neutrophil infiltration. Additionally, IL-18 inhibition lowered the expression of pro-inflammatory factors, such as IL-1β and the M1 microglia/macrophage marker Ccl17, while enhancing the expression of the M2 microglia/macrophage marker Arginase 1. Collectively, our findings demonstrate that IL-18 inhibition promotes motor recovery and facilitates the polarization of M1 microglia/macrophages to the M2 phenotype, thereby fostering a neuroprotective immune microenvironment in mice with SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Developmental Biology, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Shimane, Japan.
- Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, 89-1 Enya-cho, Izumo 693-8501, Shimane, Japan.
- mAbProtein Co., Ltd., 89-1 Enya-cho, Izumo 693-8501, Shimane, Japan.
Förderung
- Japan Society for the Promotion of Science
- Senri Life Science Foundation
Zitieren
APA
Begum, E., Mahmod, M. R., Rahman, M. M., Fukuma, F., Urano, T., & Fujita, Y. (2024). IL-18 Blockage Reduces Neuroinflammation and Promotes Functional Recovery in a Mouse Model of Spinal Cord Injury. Biomolecules. https://doi.org/10.3390/biom15010016
Vancouver
Begum E, Mahmod MR, Rahman MM, Fukuma F, Urano T, Fujita Y. IL-18 Blockage Reduces Neuroinflammation and Promotes Functional Recovery in a Mouse Model of Spinal Cord Injury. Biomolecules. 2024. doi:10.3390/biom15010016
BibTeX
@article{Begum2024,
author = {Begum, Easmin and Mahmod, Md Rashel and Rahman, Md Mahbobur and Fukuma, Fumiko and Urano, Takeshi and Fujita, Yuki},
title = {IL-18 Blockage Reduces Neuroinflammation and Promotes Functional Recovery in a Mouse Model of Spinal Cord Injury},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom15010016}
}
EUVIMED